课题基金 / 基金详情

Analysis of the molecular machaism of defective T cell functions in reqularing B cell activation in various autoimmune diseases

Analysis of the molecular machaism of defective T cell functions in reqularing B cell activation in various autoimmune diseases
多种自身免疫性疾病中T细胞功能缺陷调节B细胞活化的分子机制分析
批准号:
10670428
负责人:
HIROHATA Shunsei
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

HIROHATA Shunsei的其他基金

相似基金

相关文献

中文摘要
翻译
虽然人类T细胞已被证明通过直接抑制B细胞来调节体液免疫反应,但抑制机制的确切后遗症尚未被描述。因此,本研究考察了T细胞-B细胞协同抑制B细胞反应的性质。特别关注Fas (CD95)-Fas配体(FasL)相互作用和CD40-CD40配体(CD40L)相互作用的作用。结果表明,通过CD40- cd40l直接相互作用获得的信号对体液免疫应答的结果产生双向影响,这取决于B细胞的激活状态和CD40连接的程度。此外,这些数据表明,CD40-CD40L相互作用而不是Fas-FasL相互作用可能在B细胞和抗cd3刺激的CD4+ T细胞之间的直接细胞协作中发挥更关键的作用,以防止不当活化的B细胞反应的延伸。IL-12是Th1反应的主要诱导剂。CD40L在调节免疫应答中发挥重要作用,包括T细胞依赖的B细胞激活和单核细胞和树突状细胞的细胞因子产生。接下来,我们研究了IL-12对活化的人CD4+ T细胞中CD40L表达的影响。结果表明,IL- 12可增强活化CD4+ T细胞的CD40L表达,而不依赖于IFN-γ的产生。提示IL-12诱导的Th1应答可能通过上调CD40L表达,在调节体液免疫应答中发挥重要作用。米佐比滨已被证明对类风湿关节炎和狼疮性肾炎有有益的治疗作用,这两种疾病都涉及到异常的B细胞功能。先前的研究表明,米佐利滨直接抑制人类B细胞的功能。我们在分子水平上详细探讨了米佐利滨抑制人B细胞反应的机制。结果表明,米佐利滨通过下调细胞周期蛋白A mRNA的稳定性来抑制细胞周期蛋白A mRNA在人B细胞中的表达,从而下调B细胞的应答。少
英文摘要
Although human T cells have been shown to regulate humoral immune responses by directly inhibiting B cells, the precise sequelae for the mechanism of suppression have not yet been delineated. The present study therefore examined the nature of T cell-B cell collaboration to suppress B cell responses. Special attention was directed to the role of Fas (CD95)-Fas ligand (FasL) interactions and CD40-CD40 ligand (CD40L) interactions. The results indicate that signals achieved by direct interactions through CD40-CD40L exert bidirectional effects on the outcome of humoral immune responses depending on the state of activation of B cells and on the extent of CD40 ligation. Moreover, the data suggest that CD40-CD40L interactions rather than Fas-FasL interactions may play more critical roles in direct cellular collaboration between B cells and anti-CD3 stimulated CD4+ T cells to prevent the extention of responses of inappmpriately activated B cells.IL-12 is the prominent inducer of Th1 responses i … More n human and in the mouse. CD40L plays important roles in regulation of immune responses, including T cell-dependent activation of B cells and cytokine production by monocytes and dendritic cells. We next examined the influences of IL-12 on the CD40L expression a activated human CD4+ T cells. The results indicate that IL- 12 enhances the CD40L expression of activated CD4+ T cells independently of the IFN-γ production. The data thus suggest that Th1 responses induced by IL-12 might play an important role in regulation of humoral immune responses through up-regulated CD40L expression.Mizoribine has been shown to have beneficial effects in the treatment of rheumatoid arthritis and lupus nephritis, in which abnormal B cell functions are involved. Previous studies demonstrated that mizoribine directly suppresses the function of human B cells. We explored in detail the mechanism of the suppression of human B cell responses by mizoribine at the molecular level. The results indicate that mizoribine suppresses the expression of cyclin A mRNA in human B cells by downregulating its stability, and thus downregulates their responses. Less
期刊论文(33)
专著(0)
科研奖励(0)
会议论文
Hirohata S: "Synergistic inhibition of human B cell activation by gold soidum thiomalate and auranofin"Clin Immunol. 91. 226-233 (1999)
Hirohata S:“硫代苹果酸金钠和金诺芬对人类 B 细胞活化的协同抑制”ClinImmunol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hirohata S, et al.: "Low-dose weekly methotexate for progressive neuropsychiatric manifestations in Behcet's disease."J Neurol Sci.. Vol.159. 181-185 (1998)
Hirohata S 等人:“每周低剂量甲氨蝶呤治疗白塞氏病的进行性神经精神表现。”J Neurol Sci.. Vol.159。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hirohata S: "Human Th1 responses driven by IL-12 are associated with enhanced expression of CD40 ligand."Clin Exp Immunol. 115. 78-85 (1999)
Hirohata S:“IL-12 驱动的人类 Th1 反应与 CD40 配体表达的增强有关。”Clin Exp Immunol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hirohata S: "Enhanced interleukin-6 messenger RNA expression by neuronal cells in a patient with neuropsychiatric systemic lupus erythematosus"Arthritis Rheum. 42. 2729-2730 (1999)
Hirohata S:“神经精神系统性红斑狼疮患者神经元细胞白细胞介素 6 信使 RNA 表达增强”大黄关节炎。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 30 条
    Analysis of the mechanism of production of pathologic autoantibodies
    • 批准号:
      23591447
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      HIROHATA Shunsei
    • 依托单位:
    Analysis of anti-neuronal antibodies in neuropsychiatric systemic lupus erythematosu
    • 批准号:
      20591175
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      HIROHATA Shunsei
    • 依托单位:
    Molecular analysis of the abnormal expression of CD 154 in T cells as a mechanism of induction of autoinimune disease.
    • 批准号:
      14570431
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2002
    • 负责人:
      HIROHATA Shunsei
    • 依托单位:
    Investigation into the roles of autoantibodies in the pathogenesis of central nervous system lupus erythematosus.
    • 批准号:
      12670438
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2000
    • 负责人:
      HIROHATA Shunsei
    • 依托单位:
    国内基金
    海外基金
    内皮细胞源性CXCL10介导IFN-γ依赖性巨噬细胞代谢重编程在抗汉塞巴尔通体感染中的作用机制研究
    KW6002通过调控IFN-γ炎症通路及类淋巴功能改善MS-ON病理的机制研究
    IFN-γ微球经肝动脉递送协同PD-1抑制剂抗肝癌的增效机制与免疫微环境重塑
    • 批准号:
      2026JJ80633
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      王小军
    • 依托单位:
    IFN-γ信号激活通过自噬缓解CDDP诱导的心脏毒性
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      曹莹莹
    • 依托单位: